Cost Curve News - News - https://www.costcurvenews.com/blog/page/10/

The Government and Companies Are Both Preparing for the (As Yet Unannounced) Pharma Tariffs

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

APEX | A New Reuters Analysis of 2024 Launch Prices Doesn’t Say What Reuters Thinks It Does

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

The CBO Drops Numbers on What the Reconciliation Bill Will Cost (and Save), With Insight on Orphans, PBMs, and Pharmacies

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

Breaking News on MFN ‘Targets’ … and a Review of the Right’s Reaction to the Policy

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

Reactions to Friday’s 340B Ruling Roll In

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

APEX | 340B Decision Means that the Government Is on the Spot to Determine the Fate of the ‘Rebate Model’

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

APEX | Same Arguments, Same Examples: Where Trump and Bernie Are Lined Up on International Prices

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

The Trump MFN EO: Terrible as a Policy Prescription … but Solid as a PR Stunt

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

APEX | Trump’s MFN Executive Order Underwhelms Just About Everyone

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

Trump’s Plan for MFN: Largely Wishful Thinking, With Thin Gruel for Policy Wonks

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

The Government and Companies Are Both Preparing for the (As Yet Unannounced) Pharma Tariffs

APEX | A New Reuters Analysis of 2024 Launch Prices Doesn’t Say What Reuters Thinks It Does

The CBO Drops Numbers on What the Reconciliation Bill Will Cost (and Save), With Insight on Orphans, PBMs, and Pharmacies

Breaking News on MFN ‘Targets’ … and a Review of the Right’s Reaction to the Policy

Reactions to Friday’s 340B Ruling Roll In

APEX | 340B Decision Means that the Government Is on the Spot to Determine the Fate of the ‘Rebate Model’

APEX | Same Arguments, Same Examples: Where Trump and Bernie Are Lined Up on International Prices

The Trump MFN EO: Terrible as a Policy Prescription … but Solid as a PR Stunt

APEX | Trump’s MFN Executive Order Underwhelms Just About Everyone

Trump’s Plan for MFN: Largely Wishful Thinking, With Thin Gruel for Policy Wonks

Latest Posts

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Popular

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Tariffs and MFN Dominate the Headlines, But Details Remain Scant

Latest News

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

Subcribe To Newsletter